BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 55 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,587,500 | -1.2% | 15,000,000 | 0.0% | 0.69% | +19.7% |
| Q2 2023 | $14,771,520 | -4.3% | 15,000,000 | 0.0% | 0.57% | -15.7% |
| Q1 2023 | $15,427,185 | -59.6% | 15,000,000 | -58.2% | 0.68% | -50.2% |
| Q4 2022 | $38,201,058 | -16.2% | 35,910,000 | -21.8% | 1.37% | -17.1% |
| Q3 2022 | $45,604,000 | +0.1% | 45,910,000 | 0.0% | 1.65% | -5.1% |
| Q2 2022 | $45,566,000 | -0.9% | 45,910,000 | 0.0% | 1.74% | +1.0% |
| Q1 2022 | $46,002,000 | -4.4% | 45,910,000 | 0.0% | 1.72% | +5.0% |
| Q4 2021 | $48,118,000 | +0.9% | 45,910,000 | 0.0% | 1.64% | +16.8% |
| Q3 2021 | $47,675,000 | -0.3% | 45,910,000 | 0.0% | 1.40% | -6.5% |
| Q2 2021 | $47,834,000 | +1.0% | 45,910,000 | 0.0% | 1.50% | +3.7% |
| Q1 2021 | $47,356,000 | +9.6% | 45,910,000 | +13.9% | 1.45% | -4.9% |
| Q4 2020 | $43,210,000 | +2.0% | 40,300,000 | 0.0% | 1.52% | -22.4% |
| Q3 2020 | $42,361,000 | -17.3% | 40,300,000 | -3.1% | 1.96% | -26.2% |
| Q2 2020 | $51,199,000 | +17.9% | 41,600,000 | 0.0% | 2.66% | -25.5% |
| Q1 2020 | $43,421,000 | – | 41,600,000 | – | 3.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |